Protara Therapeutics, Inc. (TARA) — DEF 14A Filings
All DEF 14A filings from Protara Therapeutics, Inc.. Browse 2 Proxy Statement reports with AI-powered summaries and risk analysis.
DEF 14A Filings (2)
-
Protara Therapeutics Files Definitive Proxy Statement
— Apr 25, 2025 Risk: medium
Protara Therapeutics, Inc. filed its definitive proxy statement on April 25, 2025, for its annual meeting on June 11, 2025. The company, formerly known as ArTar -
Protara Therapeutics Announces 2024 Annual Meeting of Stockholders
— Apr 26, 2024 Risk: low
Protara Therapeutics, Inc. (TARA) filed a Proxy Statement (DEF 14A) with the SEC on April 26, 2024. Protara Therapeutics, Inc. will hold its 2024 Annual Meeting
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX